BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Olgasi C, Cucci A, Follenzi A. iPSC-Derived Liver Organoids: A Journey from Drug Screening, to Disease Modeling, Arriving to Regenerative Medicine. Int J Mol Sci 2020;21:E6215. [PMID: 32867371 DOI: 10.3390/ijms21176215] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 10.5] [Reference Citation Analysis]
Number Citing Articles
1 Kim W, Gwon Y, Park S, Kim H, Kim J. Therapeutic strategies of three-dimensional stem cell spheroids and organoids for tissue repair and regeneration. Bioactive Materials 2023;19:50-74. [DOI: 10.1016/j.bioactmat.2022.03.039] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 Shi Y, Deng J, Sang X, Wang Y, He F, Chen X, Xu A, Wu F. Generation of Hepatocytes and Nonparenchymal Cell Codifferentiation System from Human-Induced Pluripotent Stem Cells. Stem Cells International 2022;2022:1-18. [DOI: 10.1155/2022/3222427] [Reference Citation Analysis]
3 Wang P, Fang Y, Liu Y, Yeh M. Merits of hiPSC-Derived Cardiomyocytes for In Vitro Research and Testing Drug Toxicity. Biomedicines 2022;10:2764. [DOI: 10.3390/biomedicines10112764] [Reference Citation Analysis]
4 Arjmand B, Rabbani Z, Soveyzi F, Tayanloo-beik A, Rezaei-tavirani M, Biglar M, Adibi H, Larijani B. Advancement of Organoid Technology in Regenerative Medicine. Regen Eng Transl Med . [DOI: 10.1007/s40883-022-00271-0] [Reference Citation Analysis]
5 Salg GA, Blaeser A, Gerhardus JS, Hackert T, Kenngott HG. Vascularization in Bioartificial Parenchymal Tissue: Bioink and Bioprinting Strategies. IJMS 2022;23:8589. [DOI: 10.3390/ijms23158589] [Reference Citation Analysis]
6 Lee J, Mun SJ, Shin Y, Lee S, Son MJ. Advances in liver organoids: model systems for liver disease. Arch Pharm Res . [DOI: 10.1007/s12272-022-01390-6] [Reference Citation Analysis]
7 Limongi T, Guzzi F, Parrotta E, Candeloro P, Scalise S, Lucchino V, Gentile F, Tirinato L, Coluccio ML, Torre B, Allione M, Marini M, Susa F, Fabrizio ED, Cuda G, Perozziello G. Microfluidics for 3D Cell and Tissue Cultures: Microfabricative and Ethical Aspects Updates. Cells 2022;11:1699. [DOI: 10.3390/cells11101699] [Reference Citation Analysis]
8 Fanizza F, Campanile M, Forloni G, Giordano C, Albani D. Induced pluripotent stem cell-based organ-on-a-chip as personalized drug screening tools: A focus on neurodegenerative disorders. J Tissue Eng 2022;13:204173142210953. [DOI: 10.1177/20417314221095339] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Chen X, Wen F, Li Z, Li W, Zhou M, Sun X, Zhao P, Zou C, Liu T. Identification of MAEL as a promoter for the drug resistance model of iPSCs derived from T-ALL. Cancer Med 2022. [PMID: 35488386 DOI: 10.1002/cam4.4712] [Reference Citation Analysis]
10 Jeong J, Kim TH, Kim M, Jung YK, Kim KS, Shim S, Jang H, Jang WI, Lee SB, Choi D. Elimination of Reprogramming Transgenes Facilitates the Differentiation of Induced Pluripotent Stem Cells into Hepatocyte-like Cells and Hepatic Organoids. Biology (Basel) 2022;11:493. [PMID: 35453693 DOI: 10.3390/biology11040493] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Wang J, Huang D, Yu H, Cheng Y, Ren H, Zhao Y. Developing tissue engineering strategies for liver regeneration. Engineered Regeneration 2022. [DOI: 10.1016/j.engreg.2022.02.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
12 Bishi DK, Mathapati SS, Padhi P, Venkataprasanna K, Ezhilarasu H, Ramalingam R, Rahim MHA, Venugopal JR. Advances and applications of biofiber polymer composites in regenerative medicine. Advances in Bio-Based Fiber 2022. [DOI: 10.1016/b978-0-12-824543-9.00012-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 J N, T H, J S. IPSC-derived models in Africa: An HIV perspective. Biochimie 2022. [DOI: 10.1016/j.biochi.2022.01.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Bourque K, Mnasri N, Jones-tabah J, Martins-cannavino K, Hébert TE. Drug Discovery in Induced Pluripotent Stem Cell Models. Comprehensive Pharmacology 2022. [DOI: 10.1016/b978-0-12-820472-6.00049-9] [Reference Citation Analysis]
15 Hadjittofi C, Feretis M, Martin J, Harper S, Huguet E. Liver regeneration biology: Implications for liver tumour therapies. World J Clin Oncol 2021; 12(12): 1101-1156 [DOI: 10.5306/wjco.v12.i12.1101] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
16 Wu X, Su J, Wei J, Jiang N, Ge X. Recent Advances in Three-Dimensional Stem Cell Culture Systems and Applications. Stem Cells Int 2021;2021:9477332. [PMID: 34671401 DOI: 10.1155/2021/9477332] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
17 Huang MF, Pang LK, Chen YH, Zhao R, Lee DF. Cardiotoxicity of Antineoplastic Therapies and Applications of Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Cells 2021;10:2823. [PMID: 34831045 DOI: 10.3390/cells10112823] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
18 Aboul-Soud MAM, Alzahrani AJ, Mahmoud A. Induced Pluripotent Stem Cells (iPSCs)-Roles in Regenerative Therapies, Disease Modelling and Drug Screening. Cells 2021;10:2319. [PMID: 34571968 DOI: 10.3390/cells10092319] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
19 Ofir R. hiPSC-Derived Cells as Models for Drug Discovery. Int J Mol Sci 2021;22:8626. [PMID: 34445332 DOI: 10.3390/ijms22168626] [Reference Citation Analysis]
20 Nguyen R, Da Won Bae S, Qiao L, George J. Developing liver organoids from induced pluripotent stem cells (iPSCs): An alternative source of organoid generation for liver cancer research. Cancer Lett 2021;508:13-7. [PMID: 33771683 DOI: 10.1016/j.canlet.2021.03.017] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
21 Wang AYL. Human Induced Pluripotent Stem Cell-Derived Exosomes as a New Therapeutic Strategy for Various Diseases. Int J Mol Sci 2021;22:1769. [PMID: 33578948 DOI: 10.3390/ijms22041769] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
22 Huang D, Zhang X, Fu X, Zu Y, Sun W, Zhao Y. Liver spheroids on chips as emerging platforms for drug screening. Engineered Regeneration 2021;2:246-56. [DOI: 10.1016/j.engreg.2021.10.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
23 Fritsche E, Haarmann-Stemmann T, Kapr J, Galanjuk S, Hartmann J, Mertens PR, Kämpfer AAM, Schins RPF, Tigges J, Koch K. Stem Cells for Next Level Toxicity Testing in the 21st Century. Small 2021;17:e2006252. [PMID: 33354870 DOI: 10.1002/smll.202006252] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]